• Dynamic Dashboard
        • Dynamic Dashboard

        • Investment Gallery

          The Investment Gallery presents basic and applied research projects and/or investments...

        • Incentives Gallery

          The Incentives Gallery of the Dynamic Dashboard captures, displays and tracks in a single....

        • Analysis Reports and Recommendations

          The Global AMR R&D Hub’s Dynamic Dashboard – a platform that continuously collects...

        • Pipeline Gallery

          The Pipeline Gallery shows the antibacterial products in clinical development or...

        • Dynamic Dashboard Library

          The Dynamic Dashboard is designed to be a resource for everyone working in the field of AMR...

  • One Health
        • One Health

          Human, animal, plant and environmental health are inextricably linked. One Health recognises the connectiveness and integrates a holistic approach involving experts and relevant disciplines from all relevant sectors and industries.

        • Animal Health

          The rise of antimicrobial resistance (AMR) is a major global threat to human and animal health and largely driven...

        • Human Health

          The rise of antimicrobial resistance (AMR) has been recognized as one of the largest global.

  • News
  • Events
  • Publications
  • Our Work
        • Our Work

          To achieve its vision and objectives, as outlined in the Terms of Reference, the Global AMR R&D Hub is progressing work under its three strategic pillars. Key activities under each of the pillars are outlined below. The 2018-2021 Work Plan of the Global AMR R&D Hub highlights the key activities.

        • Key Activities

          Consulting with a Stakeholder Group, consisting of 20 members from non-government ...

        • Studies

          Antibiotics have been a critical tool since the discovery of penicillin in 1928...

        • Collaboration

          The Global AMR R&D Hub consults, cooperates and collaborates with different partners ...

        • Operational Documents

          Antibiotics have been a critical tool since the discovery of penicillin in 1928...

        • News & Events
        • About
  • Dynamic Dashboard
    • Investment Gallery
    • Pipeline GalleryGrowing mismatch between antibacterial innovation and global patient needs
    • Incentives Gallery
    • Dynamic Dashboard LibraryCategories and DefinitionsInfectious Agents in ScopeUser GuideData SourcesMethodologyFactsheet
    • Analysis Reports and RecommendationsAnnual Report 2021: The Global AMR R&D Funding Landscape
  • One Health
    • Animal HealthExpert ConsultationCollaboration with STAR-IDAZ
    • Human Health
  • News
  • Events
  • Publications
  • Our Work
    • The Global AMR R&D Hub – At a Glance
    • Key Activities
    • Collaboration
    • StudiesPolicy Maker Perspectives on IncentivesNational Health System Tools to Improve ValuationMarket potential and priority patient needs
    • Operational DocumentsMonitoring & Evaluation
  • News & Events
    • AMR Snapshots
    • Events
    • NewsG20 Bali Leaders’ Declaration3rd Global High-Level Ministerial Conference on AMR
    • EventsGlobal AMR R&D Hub Annual Meeting 2022Webinar "How to use the Global AMR R&D Hub's Dynamic Dashboard"Workshop "Increasing Investments for AMR R&D"
    • Newsletter Global AMR R&D Hub
    • Press & MediaThe Hub in the Media
  • About
    • Vision & Objectives
    • Strategy
    • Board of Members
    • Global AMR R&D Hub Secretariat
    • Stakeholder Group
    • Contact us

/ Archives

AMR Snapshots: Edition 2: Dr. John Rex

We are delighted to be joined by Dr. John Rex (Editor-In-Chief, AMR. Solutions) to discuss the Hub report ‘ Estimating global patient needs and market potential for priority health technologies addressing antimicrobial resistance’ (published in August 2021).

Dr. Rex is a physician and drug developer with more than 30 years of development and policy experience focused on antimicrobial agents and a leading voice in this AMR arena. We had a great time getting to know Dr. Rex better and discussing some of the key results from the study – we even ventured into the topic of bacteriophage! Hope you enjoy watching

← End of year Newsletter out now! → AMR Snapshots: Edition 3: Dr. Elisabeth Erlacher-Vindel

About

The Global AMR R&D Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. The Hub was launched in May 2018 and is steered by a Board of Members. A Secretariat operates under the umbrella of DZIF, the German Centre for Infection Research.

Information

  • Dynamic Dashboard
  • Press & Media
  • Jobs
  • Impressum
  • Privacy Policy

Contact

+49 30 403 677 76

globalamrhub@dzif.de


Newsletter

© Copyright 2018 - 2019 | Privacy Policy | All Rights Reserved

Funded by: